Vanderbilt-Ingram Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 223 studies whose lead sponsor is Vanderbilt-Ingram Cancer Center. 33 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Vanderbilt-Ingram Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Vanderbilt-Ingram Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 223. Browse all 223 →
- Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell CarcinomaRecruitingNCT07741643Phase 1
- Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07741565Early Phase 1
- Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)RecruitingNCT07460765Phase 1
- Cemiplimab and Quad Shot Radiation for Cutaneous Squamous Cell Carcinoma in the Head and NeckRecruitingNCT07869823Early Phase 1
- Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin LymphomaRecruitingNCT07763210Phase 2
- Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT07748988Phase 1
- The Clonal Hematopoiesis & Inflammation in Vasculature Registry and BiorepositoryRecruitingNCT06701214
- PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCCNot yet recruitingNCT07836049Phase 2
- Collecting and Storing Tissue Samples From Women With or Without Breast CancerRecruitingNCT00899301
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerRecruitingNCT00897117
- Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC StudyRecruitingNCT05361720Phase 2
- Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid LeukemiaRecruitingNCT06399640Phase 1
- Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersRecruitingNCT05919108Phase 2
- Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell LymphomaRecruitingNCT07673367Phase 2
- Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck CancerRecruitingNCT06819228Phase 1
- Circulating Tumor DNA to Guide Changes in Standard of Care ChemotherapyRecruitingNCT05770531Phase 2
- Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT06016855Phase 4
- Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell CarcinomaRecruitingNCT07217028Phase 1
- Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted TherapyRecruitingNCT06828588Early Phase 1
- High-Resolution PET-CT Imaging for Surgical Margin VisualizationRecruitingNCT06915454Not applicable
- Molecular Predictors of Cancer in Patients at High Risk of Lung CancerRecruitingNCT00898313
- Evaluating 111In Panitumumab for Nodal Staging in Head and Neck CancerRecruitingNCT05901545Phase 1
- EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation SequencingRecruitingNCT06105801Phase 4
- Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck CancerRecruitingNCT05945875Phase 1
- Cohort to Augment the Understanding of Sarcoma Survivorship Across the LifespanRecruitingNCT06482957
- Studying Health Outcomes After Treatment in Patients With RetinoblastomaRecruitingNCT03932786
- Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of TreatmentRecruitingNCT01205815
- Inherited CAncer REgistryRecruitingNCT03231891
- Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue SarcomasRecruitingNCT04506008Phase 2
- Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2
- Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation TherapyRecruitingNCT05996432Early Phase 1
- Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body IrradiationRecruitingNCT06110572Phase 1/2
- Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell TransplantRecruitingNCT03415139
- Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 InhibitorsTerminatedNCT05764395Phase 2
- Chemoprevention of Gastric CarcinogenesisCompletedNCT02794428Phase 2
- Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis FungoidesSuspendedNCT02702310
- BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT01791478Phase 1
- Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL TrialActive, not recruitingNCT06593106Not applicable
- TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to HydroxyureaCompletedNCT02493530Phase 1
- Early Detection of Lung CancerActive, not recruitingNCT03181256
- A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary NodulesActive, not recruitingNCT06074133
- A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast CancerCompletedNCT03962647Early Phase 1
- Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary NodulesActive, not recruitingNCT06638398Not applicable
- Metabolism Informed Smoking Treatment: The MIST RCTCompletedNCT04590404Phase 3
- Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle AspirationCompletedNCT04250194Not applicable
- Improving Care After Inherited Cancer TestingActive, not recruitingNCT04763915Not applicable
- Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung CancerTerminatedNCT06140407Phase 2
- Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid LeukemiaCompletedNCT02658487Phase 2
- Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient SettingCompletedNCT05108805Phase 4
- Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast CancerCompletedNCT03206203Phase 2